UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.51B |
| 2 |
Accenture
ACN
|
+$1.43B |
| 3 |
Linde
LIN
|
+$1.18B |
| 4 |
Prologis
PLD
|
+$1.06B |
| 5 |
Microsoft
MSFT
|
+$908M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$784M |
| 3 |
Blackrock
BLK
|
+$737M |
| 4 |
Meta Platforms (Facebook)
META
|
+$506M |
| 5 |
UBS Group
UBS
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.2% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Compass
COMP
$9.52B
| $4.88M | ﹤0.01% |
798,030
+47,444
| +6% | +$233K |
|
1577
Inter&Co
INTR
$2.36B
| $4.87M | ﹤0.01% |
+731,761
| New | +$5.06M |
|
1578
Pricesmart
PSMT
$5.21B
| $4.87M | ﹤0.01% |
53,096
+503
| +1% | +$43.4K |
|
1579
Goodyear
GT
$1.74B
| $4.86M | ﹤0.01% |
549,189
-62,285
| -10% | -$588K |
|
1580
Boston Beer
SAM
$1.86B
| $4.84M | ﹤0.01% |
16,753
-2,450
| -13% | -$683K |
|
1581
Green Brick Partners
GRBK
$3.03B
| $4.83M | ﹤0.01% |
57,848
-5,260
| -8% | -$380K |
|
1582
Dyne Therapeutics
DYN
$4.95B
| $4.83M | ﹤0.01% |
134,334
+6,784
| +5% | +$270K |
|
1583
CONMED
CNMD
$1.48B
| $4.82M | ﹤0.01% |
67,062
+1,095
| +2% | +$77.3K |
|
1584
AST SpaceMobile
ASTS
$20.5B
| $4.82M | ﹤0.01% |
+184,274
| New | +$4.16M |
|
1585
BancFirst
BANF
$3.77B
| $4.79M | ﹤0.01% |
45,502
-2,453
| -5% | -$249K |
|
1586
Laureate Education
LAUR
$5.13B
| $4.79M | ﹤0.01% |
288,132
-38,427
| -12% | -$587K |
|
1587
Arcturus Therapeutics
ARCT
$200M
| $4.78M | ﹤0.01% |
205,756
+204
| +0.1% | +$4.36K |
|
1588
Grupo Cibest SA
CIB
$21.7B
| $4.77M | ﹤0.01% |
151,905
-900
| -0.6% | -$29.5K |
|
1589
Hims & Hers Health
HIMS
$7.35B
| $4.76M | ﹤0.01% |
258,661
-28,276
| -10% | -$506K |
|
1590
Magnite
MGNI
$3.47B
| $4.76M | ﹤0.01% |
343,961
+10,994
| +3% | +$150K |
|
1591
Madrigal Pharmaceuticals
MDGL
$11.9B
| $4.74M | ﹤0.01% |
22,356
-2,253
| -9% | -$576K |
|
1592
John Wiley & Sons Class A
WLY
$2.62B
| $4.74M | ﹤0.01% |
98,284
+342
| +0.3% | +$15.7K |
|
|
SVC
1593
Service Properties Trust
SVC
$1.05B
| $4.74M | ﹤0.01% |
207,682
+165,753
| +395% | +$4.12M |
|
1594
J&J Snack Foods
JJSF
$1.68B
| $4.73M | ﹤0.01% |
27,486
-4,057
| -13% | -$681K |
|
1595
Agilysys
AGYS
$3.02B
| $4.73M | ﹤0.01% |
43,413
-5,717
| -12% | -$612K |
|
1596
Alamo Group
ALG
$2.06B
| $4.73M | ﹤0.01% |
26,250
-913
| -3% | -$163K |
|
1597
Palomar
PLMR
$3.46B
| $4.73M | ﹤0.01% |
49,942
-1,727
| -3% | -$159K |
|
1598
Construction Partners
ROAD
$6.68B
| $4.71M | ﹤0.01% |
67,527
-9,473
| -12% | -$584K |
|
|
CPRX
1599
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.7M | ﹤0.01% |
236,222
-14,898
| -6% | -$276K |
|
|
HI
1600
DELISTED
Hillenbrand
HI
| $4.69M | ﹤0.01% |
168,642
-2,146
| -1% | -$75.4K |
|
Similar funds
UBS AM's Q3 2024 Portfolio in Review
As of Q3 2024, UBS AM held 2,899 positions worth $389B, up 12% from $349B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
UBS AM deployed $20.6B of net new capital in Q3 2024, opening 104 new positions and adding to 979 existing holdings. Its largest new stake was Cemex: 31,204,197 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $818M trimmed.
- UBS AM's largest Q3 2024 buy was Cemex: 31,204,197 shares worth $190M.
- UBS AM added most to Pinduoduo in Q3 2024, an estimated $1.51B increase.
- UBS AM's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $818M.
- UBS AM fully exited Vanguard Russell 1000 Growth ETF in Q3 2024, selling an estimated $128M.
- UBS AM's ten largest holdings make up 29% of its $389B portfolio in Q3 2024.
- UBS AM opened 104 new positions and closed 100 in Q3 2024.
- UBS AM's portfolio value rose 12% quarter-over-quarter to $389B.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.